Jinhe Biotechnology Co.Ltd(002688)
It was decided at the 10th meeting of the audit committee of the 5th board of directors that Jinhe Biotechnology Co.Ltd(002688) (hereinafter referred to as “the company”) the 10th meeting of the audit committee of the 5th board of directors was notified by e-mail on April 8, 2022 and held by on-site and communication on April 20, 2022. Members Mr. Yao Minfu and Mr. Lu Wenbing attended the meeting by communication. The meeting was presided over by the convener, Ms. Xie Xiaoyan. There were 3 members who should attend the meeting and 3 members who actually attended the meeting. The number of members of the audit committee of the board of directors met the laws and regulations, and the meeting was legal and valid. The meeting shall be held in accordance with the company law of the people’s Republic of China and other laws and regulations and the articles of association. The members attending the meeting deliberated and adopted the following proposals by means of on-site and communication voting:
1、 The proposal on the company’s 2021 annual audit report was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
Agree to submit this proposal to the board of directors for deliberation.
2、 The proposal on the company’s 2021 annual financial statement was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
3、 The proposal on the company’s 2022 financial budget plan was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
4、 The proposal on the company’s profit distribution plan for 2021 was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
Agree to submit this proposal to the board of directors for deliberation.
5、 The proposal on the full text and summary of the company’s 2021 annual report was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
6、 The special report on the use and deposit of the company’s raised funds in 2021 was reviewed and adopted by 3 votes in favor, 0 against and 0 abstention.
Agree to submit this proposal to the board of directors for deliberation.
7、 The proposal on renewing the appointment of ShineWing Certified Public Accountants (special general partnership) as the company’s audit institution in 2022 was deliberated and adopted by 3 votes in favor, 0 against and 0 abstention.
Agree to submit this proposal to the board of directors for deliberation.
8、 The self-evaluation report on the company’s internal control in 2021 was deliberated and adopted with 3 affirmative votes, 0 negative votes and 0 abstention.
Agree to submit this proposal to the board of directors for deliberation.
9、 The proposal on the estimated related party transactions between the company and Inner Mongolia Jinhe construction and installation Co., Ltd. in 2022 was deliberated and adopted by 3 votes in favor, 0 against and 0 abstention. 10、 The proposal on the provision for asset impairment was reviewed and adopted with 3 in favor, 0 against and 0 abstention.
Agree to submit this proposal to the board of directors for deliberation.
This resolution.
Jinhe Biotechnology Co.Ltd(002688) board of directors audit committee
April 20, 2022
